5 unchanged sentences
The Series PR OP Units are not listed on any exchange and are not traded.
−Removed: On February 26, 2025, the last sales price for our Series ES OP Units on the NYSE Arca was $8.76 per unit.
−Removed: On February 26, 2025, the last sales price for our Series 60 OP Units on the NYSE Arca was $9.45 per unit.
−Removed: On February 26, 2025, the last sales price for our Series 250 OP Units on the NYSE Arca was $8.18 per unit.
+Added: On February 24, 2026, the last sales price on the NYSE Arca for our Series ES OP Units, Series 60 OP Units and Series 250 OP Units was $5.80, $5.59 and $5.55, respectively, per unit.
As of February 24, 2026, we had approximately 529 registered holders of Series PR OP Units, 714 registered holders of Series ES OP Units, 207 registered holders of Series 60 OP Units and 157 registered holders of Series 250 OP Units.
4 unchanged sentences
Our actual results of operations will be affected by a number of factors, including the revenue we receive from our properties, our operating expenses, interest expense, the ability of our tenants to meet their obligations and unanticipated expenditures.
−Removed: We declared dividends of $0.035 per share for each quarter of 2024, which equates to an annualized rate of $0.14 per share.
+Added: ESRT declared dividends of $0.035 per share for each quarter of 2025, which equates to an annualized rate of $0.14 per share.
We and ESRT's Board will continue regular reviews of our dividend and capital allocation policies.
Distributions declared by us will be authorized by ESRT's Board in its sole discretion out of funds legally available therefore and will be dependent upon a number of factors, including restrictions under applicable law, our capital requirements and the distribution requirements necessary to maintain ESRT's qualification as a REIT.
−Removed: See ITEM 1A, "Risk Factors," and ITEM 7, "Management's Discussion and Analysis of Financial Conditions and Results of Operations," of this Annual Report on Form 10-K, for information regarding the sources of funds used for dividends and for a discussion of factors, if any, which may adversely affect our ability to make distributions to our securityholders.
+Added: See ITEM 1A, "Risk Factors," and ITEM 7, "Management's Discussion and Analysis of Financial Conditions and Results of Operations," of this Annual Report on Form
+Added: 10-K, for information regarding the sources of funds used for dividends and for a discussion of factors, if any, which may adversely affect our ability to make distributions to our securityholders.
Recent Sales of Unregistered Securities Use of Proceeds from Registered Securities
2 unchanged sentences
ESRT's Board of Directors authorized the repurchase of up to $500.0 million of ESRT Class A common stock and our Series ES, Series 250 and Series 60 operating partnership units from January 1, 2024 through December 31, 2025.
+Added: Upon expiration of this program, ESRT's Board of Directors authorized the repurchase of up to $500.0 million of ESRT Class A common stock and our Series ES, Series 250 and Series 60 operating partnership units during the period from January 1, 2026 through December 31, 2027.
Under the program, ESRT may purchase ESRT Class A common stock and we may purchase our Series ES, Series 250 and Series 60 operating partnership units in accordance with applicable securities laws from time to time in the open market or in privately negotiated transactions.
1 unchanged sentence
The authorization does not obligate ESRT or us to acquire any particular amount of securities, and the program may be suspended or discontinued at ESRT's and our discretion without prior notice.
−Removed: As of December 31, 2024, ESRT had $500.0 million remaining of the authorized repurchase amount.
−Removed: There were no repurchases of equity securities during the three-month period ended December 31, 2024 under this repurchase program.
−Removed: See "Financial Statements — Note 10 Capital" in this Annual Report on Form 10-K.
+Added: As of December 31, 2025, we had $491.9 million remaining of the authorized repurchase amount for the 2024-2025 period.
+Added: The following table summarizes ESRT's repurchases of equity securities in each of the three months ended December 31, 2025 under the repurchase program for the 2024-2025 period.
+Added: Period Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plan Maximum Approximate Dollar Value Available for Future Purchase (in thousands)
+Added: October 1 - October 31, 2025 — $ — — $ 497,852
+Added: November 1 - November 30, 2025 — $ — — $ 497,852
+Added: December 1 - December 31, 2025 888,188 $ 6.73 888,188 $ 491,878
+Added: There were no repurchases of equity securities yet under the new 2026-2027 repurchase program.
+Added: See "Financial Statements — Note 10 Equity" in this Annual Report on Form 10-K.
Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.